Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality. Conference

Chakraborty, Asmi, Perez, Mariana, Mohammed, Norhan BB et al. (2021). Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality. . CANCER RESEARCH, 81(13),

International Collaboration

cited authors

  • Chakraborty, Asmi; Perez, Mariana; Mohammed, Norhan BB; Wells, Michael; Wilmott, James S; Thompson, John F; Haslam, Stuart M; Wang, Wei; Scolyer, Richard A; Murphy, George F; Dimitroff, Charles J

authors

date/time interval

  • April 10, 2021 -

publication date

  • July 1, 2021

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • PA, Philadelphia

Conference

  • Annual Meeting of the American-Association-for-Cancer-Research (AACR)

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 81

issue

  • 13